Independentthinker
Diamond Member
- Oct 15, 2015
- 20,270
- 16,481
- 2,288
Biden's high-stakes booster tension with Moderna
A disagreement between the Biden administration and Moderna over booster shot details has thrown a wrench in the administration's plans, and may result in the booster effort beginning with only some Pfizer recipients later this month. Why it matters: How the dispute shakes out could have...
- The Biden administration wants to see data for boosting with 100 micrograms as well. The FDA needs both datasets to evaluate what elicits a more durable immune response, a senior Biden administration official told Axios.
The big picture: The Biden administration's booster effort is already under fire for getting ahead of the data.
- The administration argues that it doesn't have any time to lose when it comes to staying ahead of the virus.
- The administration argues that it doesn't have any time to lose when it comes to staying ahead of the virus.
- Wait a minute, is this the Biden administration setting policy for the FDA, IE the Biden administration is telling the FDA what they want the science to be, instead of the other way around?
- vaccine effectiveness at preventing infection appears to have dropped significantly over time.
- Boosting with a half-dose bumps a person's immune response up to well above the level it was at two weeks after their second dose of the vaccine, the company said in August.
- Wait a minute, what was that? A 50 micrograms booster shot bumps a person's immune response up to well above the level it was at two weeks after their second dose of the vaccine and the Biden administration says that's not good enough?
